| 증례 / Octreotide 사용으로 감소를 보인 전이성 간 카르시노이드 종양 1예 ( A Case of Hepatic Carcinoid Tumor Regression with Octreotide ) |
|
|
| A Case of Hepatic Carcinoid Tumor Regression with Octreotide |
| Hee-Jin Choi, M.D., Sang-Kyun Woo, M.D., Kyung-Hee Suh, M.D., Seung-Min Baek, M.D.,
Hyo-Jong Beak, M.D., Sang-Moon Lee, M.D., Won-Ho Kim, M.D., Sung-Ho Kim, M.D.,
Ik-Su Kim, M.D.*, Kyung-Rak Shon, M.D.* |
| Department of Internal Medicine, Pathology *, Taegu Fatima Hospital |
|
|
|
|
| ABSTRACT |
|
|
Somatostatin analogue octreotide is commonly used for the treatment of carcinoid syndrome. Octreotide also has an antiproliferative effect in neuroendocrine tumors and has demonstrated tumor reduction in patients having advanced carcinoid tumor. This is a case report of a patient who had metastatic liver carcinoid tumor and showed marked regression of liver metastasis after octreotide therapy. (Korean J Hepatol 2001;7:100-103) |
| KeyWords:
Neoplasm/ Liver/ Metastatic/ Carcinoid tumor, Octreotide |
|
|
PDF Links
Full text via DOI
Download Citation
